SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-17-064388
Filing Date
2017-10-27
Accepted
2017-10-27 17:03:25
Documents
4
Period of Report
2017-12-13
Effectiveness Date
2017-10-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a17-24132_1def14a.htm DEF 14A 423088
2 GRAPHIC g241321bei001.jpg GRAPHIC 5684
3 GRAPHIC g241321cai001.gif GRAPHIC 209215
4 GRAPHIC g241321bci001.jpg GRAPHIC 5684
  Complete submission text file 0001104659-17-064388.txt   728248
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36856 | Film No.: 171160082
SIC: 2834 Pharmaceutical Preparations